肥厚型心肌病的诊断与评估:JACC 最新综述
肥厚型心肌病(HCM)是一种相对常见的全球性遗传性心脏病,患病率约为1:200至1:500,据此推断美国可能有75万人受累。横断面数据显示仅一小部分被临床诊断,提示认识不足。超声心动图和心脏磁共振是可靠诊断手段,家系筛查可识别表型亲属,基因分析可识别无左室肥厚的临床前携带者。
要点
- HCM患病率约1:200-1:500,美国或有75万患者,但临床诊断率低。
- 超声心动图和心脏磁共振是HCM可靠诊断的核心影像手段。
- 家系影像筛查识别表型亲属,基因分析识别无左室肥厚的临床前携带者。
核心结论
- HCM是一种相对常见的全球性遗传性心脏病,临床认识不足导致诊断率偏低,需重视影像学诊断和家系筛查。
研究设计与样本
- 本文为JACC最新综述,总结HCM的诊断与评估要点,未报告系统检索范围或原始研究样本量。
主要发现
- HCM患病率约为1:200至1:500,据此推断美国可能有75万人受累。
- 横断面数据显示仅一小部分HCM患者被临床诊断,提示存在认识不足。
- 超声心动图和心脏磁共振是可靠诊断HCM的影像手段。
- 家系无创影像筛查可识别具有HCM表型的亲属,基因分析可识别无左室肥厚的临床前肌节基因携带者。
关键数值与推荐
- HCM患病率约为1:200至1:500,据此推断美国可能有75万人受累。
临床怎么用
- 临床应使用超声心动图和心脏磁共振进行HCM可靠诊断,并开展家系影像筛查和基因分析以识别受累亲属及临床前携带者。
- 初始患者评估应全面,包括准确描绘HCM表型和家族史、风险分层以及区分梗阻性与非梗阻性形式。
局限性
- 原文未报告综述的检索策略、纳入文献数量或系统评价方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart disease, with complex phenotypic and genetic expression and natural history, affecting both genders and many races and cultures. Prevalence is 1:200-1:500, largely based on the disease phenotype with imaging, inferring that 750,000 Americans may be affected by HCM. However, cross-sectional data show that only a fraction are clinically diagnosed, suggesting under-recognition, with most clinicians exposed to small segments of the broad disease spectrum. Highly effective HCM management strategies have emerged, altering clinical course and substantially lowering mortality and morbidity rates. These advances underscore the importance of reliable HCM diagnosis with echocardiography and cardiac magnetic resonance. Family screening with noninvasive imaging will identify relatives with the HCM phenotype, while genetic analysis recognizes preclinical sarcomere gene carriers without left ventricular hypertrophy, but with the potential to transmit disease. Comprehensive initial patient evaluations are important for reliable diagnosis, accurate portrayal of HCM and family history, risk stratification, and distinguishing obstructive versus nonobstructive forms.
引用
- Maron BJ, Desai MY, Nishimura RA, et al. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022. PMID: 35086660. doi:10.1016/j.jacc.2021.12.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。